ATE501258T1 - Lawsonia intracellularis impfstoff - Google Patents
Lawsonia intracellularis impfstoffInfo
- Publication number
- ATE501258T1 ATE501258T1 AT05104073T AT05104073T ATE501258T1 AT E501258 T1 ATE501258 T1 AT E501258T1 AT 05104073 T AT05104073 T AT 05104073T AT 05104073 T AT05104073 T AT 05104073T AT E501258 T1 ATE501258 T1 AT E501258T1
- Authority
- AT
- Austria
- Prior art keywords
- relates
- lawsonia intracellularis
- nucleic acid
- detection
- dna
- Prior art date
Links
- 241001148567 Lawsonia intracellularis Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 108020004414 DNA Proteins 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00204660 | 2000-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501258T1 true ATE501258T1 (de) | 2011-03-15 |
Family
ID=8172486
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01204919T ATE330013T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
| AT05104073T ATE501258T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01204919T ATE330013T1 (de) | 2000-12-20 | 2001-12-14 | Lawsonia intracellularis impfstoff |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6921536B2 (de) |
| EP (2) | EP1219711B1 (de) |
| JP (1) | JP4237960B2 (de) |
| AT (2) | ATE330013T1 (de) |
| AU (1) | AU783210B2 (de) |
| CA (1) | CA2365494A1 (de) |
| DE (2) | DE60120621T2 (de) |
| DK (2) | DK1219711T3 (de) |
| ES (2) | ES2266090T3 (de) |
| HU (1) | HUP0105379A3 (de) |
| PL (1) | PL205964B1 (de) |
| PT (1) | PT1219711E (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60120621T2 (de) * | 2000-12-20 | 2006-12-14 | Intervet International B. V. | Lawsonia intracellularis Impfstoff |
| JP4256341B2 (ja) | 2002-05-29 | 2009-04-22 | ヤマサ醤油株式会社 | 新規なポリリン酸：ａｍｐリン酸転移酵素 |
| KR20060129163A (ko) * | 2003-09-12 | 2006-12-15 | 악조 노벨 엔.브이. | 로소니아 인트라셀룰라리스 서브유닛 백신 |
| KR20060134054A (ko) | 2004-01-22 | 2006-12-27 | 인터벳 인터내셔널 비.브이. | 로소니아 인트라셀룰라리스 서브유닛 백신 |
| EP1609870A1 (de) * | 2004-06-24 | 2005-12-28 | Boehringer Ingelheim Vetmedica Gmbh | Methode, um Lawsonia intracellularis zu diagnostizieren |
| MY146476A (en) * | 2004-06-24 | 2012-08-15 | Boehringer Ingelheim Vetmed | Method of diagnosing lawsonia intracellularis |
| CA2586093A1 (en) * | 2004-11-24 | 2006-06-01 | Pharmacia & Upjohn Company Llc | Methods for cultivating lawsonia intracellularis |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| EP1874804A4 (de) * | 2005-04-18 | 2009-05-20 | Boehringer Ingelheim Vetmed | Als komponente eines subunit-impfstoffs geeignetes lawsonia-protein und verfahren zu dessen herstellung und anwendung |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| US8470336B2 (en) | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
| US20080241190A1 (en) * | 2006-11-13 | 2008-10-02 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of horses against lawsonia intracellularis |
| WO2008073464A2 (en) | 2006-12-11 | 2008-06-19 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| WO2009037262A2 (en) | 2007-09-17 | 2009-03-26 | Boehringer Ingelheim Vetmedica, Inc. | Method of preventing early lawsonia intracellularis infections |
| TWI449533B (zh) * | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗 |
| TWI551295B (zh) | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗 |
| JP5723772B2 (ja) * | 2008-07-22 | 2015-05-27 | インターベット インターナショナル ベー． フェー． | 新規血清型のローソニア・イントラセルラリス細菌、その細菌に基づくワクチン、該新規ローソニア・イントラセルラリス血清型の特定に適した抗体および該抗体を製造するためのハイブリドーマ |
| KR101837768B1 (ko) | 2011-05-25 | 2018-03-12 | 건국대학교 산학협력단 | 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용 |
| US20140017268A1 (en) * | 2012-06-05 | 2014-01-16 | Regents Of The University Of Minnesota | Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections |
| RU2709197C2 (ru) | 2015-02-04 | 2019-12-17 | Интервет Интернэшнл Б.В. | Вакцина для применения против субклинической инфекции lawsonia у свиней |
| CN107206062B (zh) | 2015-02-04 | 2021-07-02 | 英特维特国际股份有限公司 | 用于针对猪中亚临床劳森氏菌感染的疫苗 |
| RU2771533C2 (ru) * | 2015-10-16 | 2022-05-05 | Канзас Стейт Юниверсити Рисерч Фаундейшн | Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения |
| CL2017002196A1 (es) | 2017-08-30 | 2017-11-17 | Univ De Concepción | Vacuna recombinante contra enteropatía proliferativa en animales. |
| CN113528683A (zh) * | 2021-07-09 | 2021-10-22 | 南京农业大学 | 一种用于检测胞内劳森菌的绝对荧光定量pcr引物对、试剂盒及检测方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310993A (en) | 1980-01-07 | 1982-01-19 | Louvers & Dampers, Inc. | Louver assembly |
| ES2056565T3 (es) | 1990-07-30 | 1994-10-01 | Akzo Nobel Nv | Virus recombinante de la enfermedad de marek. |
| WO1993004163A1 (en) | 1991-08-23 | 1993-03-04 | Massachusetts Institute Of Technology | Strain of chlamydia |
| US5610059A (en) | 1992-11-09 | 1997-03-11 | University Of Arizona | Etiological agent for porcine enteritis |
| FR2714074B1 (fr) | 1993-12-20 | 1996-03-01 | Pasteur Institut | Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs. |
| US5714375A (en) | 1995-06-05 | 1998-02-03 | Nobl Laboratories, Inc. | Ileal symbiont intracellularis propagation in suspended host cells |
| US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| US7022328B1 (en) * | 1995-11-30 | 2006-04-04 | Australian Pork Limited | Therapeutic and diagnostic compositions |
| AU775323B2 (en) | 1999-05-13 | 2004-07-29 | Agriculture Victoria Services Pty Ltd | Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
| CA2372098A1 (en) | 1999-05-13 | 2000-11-23 | Pfizer Products Inc. | Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses |
| JP2003521881A (ja) * | 1999-05-13 | 2003-07-22 | オーストラリアン ポーク リミティッド | ローソニア由来の遺伝子及び関連ＯｍｐＨポリペプチド、ぺプチド及びタンパク質並びにそれらの使用 |
| CA2372095A1 (en) | 1999-05-13 | 2000-11-23 | Pfizer Products Inc. | Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses |
| EP1094070A3 (de) | 1999-10-22 | 2002-01-09 | Pfizer Products Inc. | Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden |
| US6605696B1 (en) * | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| DE60120621T2 (de) * | 2000-12-20 | 2006-12-14 | Intervet International B. V. | Lawsonia intracellularis Impfstoff |
-
2001
- 2001-12-14 DE DE60120621T patent/DE60120621T2/de not_active Expired - Lifetime
- 2001-12-14 PT PT01204919T patent/PT1219711E/pt unknown
- 2001-12-14 AT AT01204919T patent/ATE330013T1/de active
- 2001-12-14 EP EP01204919A patent/EP1219711B1/de not_active Expired - Lifetime
- 2001-12-14 DK DK01204919T patent/DK1219711T3/da active
- 2001-12-14 ES ES01204919T patent/ES2266090T3/es not_active Expired - Lifetime
- 2001-12-14 ES ES05104073T patent/ES2360225T3/es not_active Expired - Lifetime
- 2001-12-14 DK DK05104073.1T patent/DK1586646T3/da active
- 2001-12-14 DE DE60144201T patent/DE60144201D1/de not_active Expired - Lifetime
- 2001-12-14 AT AT05104073T patent/ATE501258T1/de not_active IP Right Cessation
- 2001-12-14 EP EP05104073A patent/EP1586646B1/de not_active Expired - Lifetime
- 2001-12-18 CA CA002365494A patent/CA2365494A1/en not_active Abandoned
- 2001-12-19 JP JP2001385373A patent/JP4237960B2/ja not_active Expired - Fee Related
- 2001-12-19 PL PL351277A patent/PL205964B1/pl not_active IP Right Cessation
- 2001-12-19 HU HU0105379A patent/HUP0105379A3/hu unknown
- 2001-12-20 AU AU97371/01A patent/AU783210B2/en not_active Ceased
- 2001-12-20 US US10/034,500 patent/US6921536B2/en not_active Expired - Fee Related
-
2005
- 2005-07-13 US US11/180,997 patent/US7491401B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0105379A2 (hu) | 2003-01-28 |
| DE60120621D1 (de) | 2006-07-27 |
| AU783210B2 (en) | 2005-10-06 |
| EP1219711A2 (de) | 2002-07-03 |
| HUP0105379A3 (en) | 2004-07-28 |
| JP2003000276A (ja) | 2003-01-07 |
| ES2266090T3 (es) | 2007-03-01 |
| US6921536B2 (en) | 2005-07-26 |
| EP1586646A3 (de) | 2007-08-01 |
| ATE330013T1 (de) | 2006-07-15 |
| JP4237960B2 (ja) | 2009-03-11 |
| EP1219711B1 (de) | 2006-06-14 |
| AU9737101A (en) | 2002-06-27 |
| DK1219711T3 (da) | 2006-09-25 |
| DE60144201D1 (de) | 2011-04-21 |
| DK1586646T3 (da) | 2011-06-27 |
| US7491401B2 (en) | 2009-02-17 |
| CA2365494A1 (en) | 2002-06-20 |
| PL205964B1 (pl) | 2010-06-30 |
| HU0105379D0 (en) | 2002-02-28 |
| PL351277A1 (en) | 2002-07-01 |
| EP1586646B1 (de) | 2011-03-09 |
| DE60120621T2 (de) | 2006-12-14 |
| ES2360225T3 (es) | 2011-06-02 |
| PT1219711E (pt) | 2006-10-31 |
| US20050069559A1 (en) | 2005-03-31 |
| US20050250150A1 (en) | 2005-11-10 |
| EP1586646A2 (de) | 2005-10-19 |
| EP1219711A3 (de) | 2002-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE330013T1 (de) | Lawsonia intracellularis impfstoff | |
| ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
| DK0942983T3 (da) | Streptococcus pneumoniae-antigener og -vacciner | |
| DE60139690D1 (de) | Immunisierung gegen chlamydia pneumoniae | |
| ATE380870T1 (de) | Borrelia burgdorferi rekombinante genkonstrukte | |
| ATE450545T1 (de) | Impfstoff mit lawsonia intracellularis- untereinheit | |
| WO2003058248A3 (en) | Diagnostics and vaccines for mycrobacterium paratuberculosis infections | |
| WO2003095480A3 (en) | Brachyspira hyodysenteriae vaccine | |
| WO2004007726A3 (en) | Brachyspira hyodysenteriae vaccine | |
| ATE417106T1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| NO20081541L (no) | Ny sjo-lus vaksine | |
| ATE366583T1 (de) | Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407 | |
| PT1176192E (pt) | Vacina de helicobacter felis | |
| WO2004024769A3 (en) | Ostertagia vaccine | |
| HUP0200832A2 (hu) | Babesia canis oltóanyag | |
| TH62170A (th) | วัคซีนเชื้อก่อโรค Lawsonia intracellularis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |